Objective: To explore the completeness of tumor, node, metastasis (TNM) staging for colon and rectal cancer in the Danish Cancer Registry. : 67.0%-68.5%) and 68.1% (95% CI: 67.0%-69.1%), respectively. For both cancers, completeness decreased with increasing age and level of comorbidity, whereas differences between the sexes were minor. Over the study period, TNM completeness for colon cancer decreased from 71.3% (95% CI: 69.5%-73.0%) to 64.8% (95% CI: 63.0%-66.6%), whereas the completeness for rectal cancer remained stable over time. When using the stage algorithm, the completeness rose markedly, to 81.1% for colon cancer and 79.0% for rectal cancer. Conclusion: One-third of colon and rectal cancer cases in the Danish Cancer Registry had missing TNM stage information, which varied with age and level of comorbidity. Cancer cases with unknown staging warrant serious consideration of the methodological implications in future epidemiological studies monitoring cancer incidence and outcomes.
Introduction
Colorectal cancer (CRC) is the third most common cancer worldwide and the fourth most common cause of cancer-related death. 1 Tumor stage is a key determinant of CRC prognosis and provides guidance to the optimal planning of treatment. Furthermore, the stage is important for monitoring trends in CRC incidence and mortality across populations. The tumor, node, metastasis (TNM) stage classification is based on the anatomic extent of the tumor, including the tumor size (T), the number of lymph nodes involved (N), and the presence of metastases (M). 2 Since 1943, all incident cancers in Denmark have been recorded in the Danish Cancer Registry (DCR). 3, 4 Reporting to the DCR has been mandatory since 1987, and ascertainment of cancer cases in the registry is virtually complete. [3] [4] [5] TNM staging has been recorded for cancer cases since 2004. 4 However, no studies have hitherto examined the completeness of TNM staging in the DCR. Some studies have suggested that factors such as age, race, sex, marital status, income, and residence influence the proportion of unstaged cancers. [6] [7] [8] Given that information on TNM might not be missing at random, unstaged CRCs could bias results of studies monitoring cancer incidence and outcomes. We therefore aimed to evaluate the completeness of CRC staging in the DCR according to the TNM classification -overall, and by sex, age, year of diagnosis, and level of comorbidity.
Methods
We performed this study in Denmark, within a population of 5.4 million inhabitants. The Danish National Health Service provides free medical care by general practitioners and hospitals. All health-related services are registered with a unique ten-digit personal identifier -the CPR number -assigned since 1968 to each resident. 9 This number allows unambiguous individual-level data linkage between Danish registers.
Ascertaining patients with CRC
We used the DCR to identify patients with a primary diagnosis of CRC between January 1, 2004 and December 31, 2009. During this period, the DCR recorded cancer diagnoses according to the International Classification of Disease, 10th revision (ICD-10). 3, 4 Colon and rectal cancer cases were identified by the ICD-10 codes C18 and C19-20, respectively. From the DCR, we also obtained information on CPR number, date of diagnosis, age, sex, and TNM stage at diagnosis.
Comorbidity data
The Danish National Patient Register contains data on all nonpsychiatric discharges from hospitals in Denmark since 1977 and all outpatient visits since 1995. 10 Information includes CPR number, date of contact/discharge, and diagnoses according to ICD-10 since 1994. From the Danish National Patient Register, we obtained information on preexisting comorbidity 10 years prior to the date of CRC diagnosis using a modified version of the Charlson Comorbidity Index (CCI). The CCI is based on disease categories that are each weighted according to the adjusted risk of one-year mortality. 11, 12 Excluding CRC from the index, we defined the level of comorbidity as low (CCI score = 0), medium (CCI score = 1-2), and high (CCI score $ 3).
Statistical analysis
We calculated the completeness of TNM stage registration and the corresponding 95% confidence intervals (CIs), both overall and for each component individually (ie, T, N, and M). The completeness was defined as the number of individuals with no missing factors (ie, T1-4, N0-3, and M0-1) divided by the total number of patients. We stratified completeness by sex, age (0-39 years, 40-59 years, 60-79 years, and $ 80 years), year of colon or rectal cancer diagnosis, and CCI score.
Complete information on T, N, and M is necessary to derive a definite TNM stage in the DCR. For additional categorization of colon or rectal cancers into localized, regional, distant, or unknown stages, we designed an algorithm, allowing certain missing stage components, under the assumption that the remaining information was sufficient to provide a meaningful categorization (eg, cancers assigned T4, Nx, M1 in the DCR were categorized as "distant"; see Appendix 1). The algorithm was based on knowledge of tumor growth and clinical coding practice In addition, we restricted the analysis to histologic verified CRC cases.
Analyses were performed using SAS (v 9.2; SAS Institute, Inc, Cary, NC). Level of comorbidity according to the Charlson comorbidity index (CCI) score; Low (CCI score = 0), Medium (CCI score = 1-2), High (CCI score $ 3). Abbreviations: CI, confidence interval; T, tumour; N, node; M, metastasis.
Results

Colon cancer
Rectal cancer
Of the 8,292 rectal cancer patients diagnosed during the study period ( 
Discussion
To our knowledge, this nationwide population-based study is the first to evaluate the completeness of TNM registration of CRC in the DCR. Although the ascertaining of cancer diagnoses in the DCR is virtually complete, [3] [4] [5] we found that approximately onethird of CRC patients had missing data on TNM classification. In particular, completeness declined with increasing age and level of comorbidity. Using a clinically based stage algorithm, we showed that the proportion of staged cases rose markedly.
The completeness of CRC staging in the US Surveillance, Epidemiology, and End Results, or SEER, database appears to be higher than what we observed in the DCR. Worthington et al reported that only 5.1% of colon and 7.8% of rectal cancers were unstaged during the 1991-2002 period. 8 However, the SEER summary stage is computed using an algorithm that allows staging with one or two missing stage components. Although we also designed a stage algorithm that allowed some missing stage information, it might differ from the SEER template. Thus, the completenesses of TNM staging in the US and Danish registers is probably not directly comparable.
We found that TNM completeness varied substantially by age and level of comorbidity, which is in accordance with previous US studies. [6] [7] [8] 13, 14 In a study examining the proportion of unstaged disease at 18 cancer sites, Merill et al reported a steep increase with age. 6 Likewise, marital status, race, sex, and prognosis of the cancers influenced staging. Koroukian et al reported that patients with more comprehensive needs for care (as measured by dependence of home health care and nursing home care) were two to five times as likely to be unstaged, compared with patients with fewer needs. 13 TNM completeness for colon cancer in the DCR decreased slightly during the study period, whereas rectal cancer staging remained stable over time. In contrast, a number of studies have reported a decrease in the proportion of patients with unstaged CRCs over recent years. [6] [7] [8] In A main strength of this study is its population-based design within the setting of a uniform tax-supported health care system, largely eliminating selection bias. Our study population was identified from updated nationwide registers. Although coding errors on CRC diagnoses and comorbidities cannot be ruled out, data from the DCR and the Danish National Patient Register have been found very complete and highly valid. 3, 5, 12 Our study also had limitations. The completeness and accuracy of CRC diagnoses in the automated version of DCR (from 2004 on) have not been specifically validated. Moreover, we had no information on the underlying reasons for the missing information on TNM stages in the DCR, although plausible explanations include incomplete reporting and genuine difficulties on the part of the clinician or pathologist in determining the stage of the particular cancer case. For example, patients who initially received oncological therapy might not have been registered with complete details on TNM. We found that the most vulnerable patients were least likely to undergo staging, suggesting cessation of diagnostic procedures, including lymph node status, if fragility did not allow further treatment. We also observed that approximately 6% of CRC diagnoses were not histologically verified. However, although it might be expected that the majority of non-histologically verified cases pertained to patients with high comorbidity, restriction of the study population to histologically verified CRC cases yielded results quite similar to those presented.
The DCR is a valuable source for cancer research and statistics. Despite the high level of completeness of the diagnoses in this registry, we found that one-third of CRC patients had missing TNM-stage information, although the proportion of unstaged cases declined markedly with our use of a clinically based stage algorithm. However, completeness varied differentially with age and level of comorbidity, indicating that TNM data are not missing at random. This finding warrants serious consideration of the methodological implications in future epidemiological studies on cancer incidence and survival. 
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